The Latest Breaking News from DEA

HHS completes review of rescheduling cannabis - Roll Call

HHS completed its review of rescheduling cannabis and sent a recommendation to the DEA, the agencies confirmed.

Roll Call · Aug 30, 2023

Biden health agency recommends classifying marijuana as lower-risk, opening potential for major policy changes

President Biden ordered agency to conduct scientific review law year

The Independent UK · Aug 30, 2023

Government Continues To Deny Its Role in Adderall Shortage

While schoolchildren go without needed medication, government agencies shirk responsibility by blaming manufacturers.

Reason · Aug 25, 2023

Chasing Shadows by Miles Johnson review – criminal world

A thriller-like tale of global drugs and terrorism that may be too complex for its own good

The Guardian - UK · Aug 3, 2023

New Illinois laws affecting schools throughout the state, including cover book bans, bullying and more

A roundup of the new Illinois rules and resources that were made into law for the 2023-2024 school year.

Chicago Sun-Times · Jul 31, 2023

The Return of MDMA

Some doctors are itching to prescribe ecstasy again. How do we avoid the regulatory mistakes of the '80s?

Reason · Jul 29, 2023

Margarito Flores, Chicago cocaine kingpin who helped bring down El Chapo, will teach cops how to catch drug traffickers

One of the notorious Flores twins is to lead a seminar at the Kane County sheriff’s office — “a rare chance for us to get into the mind of the people we are trying to find,” an official says.

Chicago Sun-Times · Jul 26, 2023

What will it take to accelerate the suburban rail project in Bengaluru?

The grand, four-corridor, suburban rail network for Bengaluru, a potential game-changer to solve the city’s perennial mobility issues, is at the crossroads.

The Hindu · Jul 25, 2023

Former Venezuela spy chief pleads not guilty to US drug charges

Plea comes after Hugo Carvajal was extradited from Spain to US to face charges he coordinated drug trafficking.

Al Jazeera · Jul 20, 2023

Revolving Door: DEA’s No.2 quits amid reports of previous consulting work for Big Pharma

The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face of the opioid epidemic: Purdue Pharma

The Independent UK · Jul 19, 2023